GDSCTools for mining pharmacogenomic interactions in cancer

Bioinformatics

Volumn 34, Issue 7, 2018, Pages 1226-1228

  Cokelaer, Thomas ^a   Chen, Elisabeth ^b   Iorio, Francesco ^b   Menden, Michael P ^c   Lightfoot, Howard ^b   Saez Rodriguez, Julio ^b,d   Garnett, Mathew J ^b  

^a CNRS   (France)

^b WELLCOME TRUST SANGER INSTITUTE   (United Kingdom)

^c ASTRAZENECA   (United Kingdom)

^d RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT;

BIOLOGY; DRUG DEVELOPMENT; GENETICS; GENOMICS; HUMAN; NEOPLASM; PHARMACOGENETICS; PROCEDURES; SOFTWARE; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; COMPUTATIONAL BIOLOGY; DRUG DISCOVERY; GENOMICS; HUMANS; NEOPLASMS; PHARMACOGENETICS; SOFTWARE;

EID: 85045837625     PISSN: 13674803     EISSN: 14602059     Source Type: Journal    
DOI: 10.1093/bioinformatics/btx744     Document Type: Article

References (9)

1. Barretina, J. et al. (2012) The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature, 492, 290.
2. Cokelaer, T. et al. (2013) BioServices: A common Python package to access biological Web Services programmatically. Bioinformatics, 29, 3241-3242.
3. Garnett, M.J. et al. (2012) Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature, 483, 570-575.
4. Iorio, F. et al. (2016) A landscape of pharmacogenomic interactions in cancer. Cell, 166, 740-754.
5. Köster, J. and Rahmann, S, 2012, Snakemake-A scalable bioinformatics workflow engine. Bioinformatics, 28, 2520-2522
6. Smirnov, P. et al. (2016) PharmacoGx: An R package for analysis of large pharmacogenomic datasets. Bioinformatics, 32, 1244-1246.
7. Turei, D. et al. (2016) OmniPath: guidelines and gateway for literature-curated signaling pathway resources. Nat. Methods, 13, 966-967.
8. Vis, D.J. et al. (2016) Multilevel models improve precision and speed of IC50 estimates. Pharmacogenomics, 17, 691-700.
9. Yang, W. et al. (2013) Genomics of drug sensitivity in cancer (GDSC): A resource for therapeutic biomarker discovery in cancer cells. Nucleic Acids Res., 41, D955-D961.